Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NIH offers sterile lyophilization product

Jan. 22, 1997

TheraTech licenses pulmonary delivery devices

Jan. 22, 1997

Hybridon granted patent coverage for orally administered hybrid compounds

Jan. 21, 1997

Forbes files for U.S. patent related to membrane deficiencies

Jan. 20, 1997

IDEC licenses technology to Boehringer Ingelheim

Jan. 17, 1997

Medarex forms European subsidiary and research alliance

Jan. 17, 1997

Lilly and TheraTech drug collaboration

Jan. 16, 1997

ArQule and Signal expand drug discovery agreement

Jan. 16, 1997

NeXstar reveals new oligonucleotide synthesis method

Jan. 13, 1997

Labopharm granted US patent on drug delivery system

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...